Caxton Associates (New York)’s Zoetis ZTS Stock Holding History
Bought
Maintained
Sold
Other funds holding ZTS
Caxton Associates (New York)'s ZTS Position: Q4 2024 in Review
Caxton Associates (New York) reduced its Zoetis (ZTS) stake by 20% in Q4 2024, selling an estimated $194K and leaving 4,414 shares worth $719K. The position accounts for 0.02% of the portfolio, ranked #272.
Caxton Associates (New York) first reported a position in ZTS in Q1 2015 and has held it in 17 quarters since. The position peaked at $4.63M in Q1 2015. 1,875 funds tracked by Wall St. Rank hold ZTS as of Q4 2024.
- Caxton Associates (New York) held 4,414 shares of Zoetis worth $719K as of Q4 2024.
- Caxton Associates (New York) sold 1,087 Zoetis shares in Q4 2024, an estimated $194K.
- Zoetis made up 0.02% of Caxton Associates (New York)'s portfolio in Q4 2024, its #272 holding.
- Caxton Associates (New York) first reported a position in Zoetis in Q1 2015 and has held it in 17 quarters since.
- Caxton Associates (New York)'s Zoetis position peaked at $4.63M in Q1 2015.
- 1,875 funds tracked by Wall St. Rank held Zoetis as of Q4 2024.
Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.